Immunotherapeutic strategies to target prognostic and predictive markers of cancer. - Wikidata - wikimedia - TriplyDB

Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

http://www.wikidata.org/entity/Q37126006

about

Cancer and orofacial pain.Cancer and Referred Facial Pain.Translational medicine individualizes healthcare discovery, development and delivery. Foreword.The swinging pendulum of cancer immunotherapy personalization

P2860

Q37423829-8FE75964-8A3A-401A-A15A-E60AF29695A5 Q38531548-47A85F21-6AB2-40A4-9BE9-15080E2B8DDB Q45043969-0A96D0F4-FBB5-4726-B790-239894B3C797 Q58924840-42589BDE-8402-42AB-818D-93554678BF72

P2860

Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

http://www.wikidata.org/entity/Q37126006

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

@en

Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

@nl

type

label

Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

@en

Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

@nl

prefLabel

Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

@en

Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

@nl

P1433

Q37126006-3F0CAFD3-7AE5-497F-940C-3A838BEE57C7

P1476

Q37126006-60922DEC-3B1E-438C-A742-10273FC1272D

P2093

Q37126006-E0C489E2-37D6-40A2-9E23-6FA64F9902DD

P2860

Q37126006-00DAB228-B967-4602-97F3-994A835BD87D

Q37126006-0103F8F9-5197-498A-8ADC-9673518DB781

Q37126006-02B14207-C9C8-45A6-996F-59BE1A3C93B7

Q37126006-03F498B6-0EF9-4348-B72A-5F2588502F3C

Q37126006-03FE01AD-82C5-4412-9BFF-BC12954EB628

Q37126006-050AE01F-28F8-432E-ACD3-A608BC9539D8

Q37126006-0B32FEDD-1FA1-439A-B532-DFAAF657EBAE

Q37126006-0BC9F24C-8013-4505-BE28-B71F62F59E22

Q37126006-0E228F06-C12E-447E-BD4C-FF5D6C8C10A5

Q37126006-0F72B9B6-9C35-4A6E-B4D3-37EC03D41CEA

P304

Q37126006-17F2BDDE-DED2-4B2D-8CAD-F6CD84C9D080

P31

Q37126006-2F5AC659-413E-4C99-B79D-7BA16467AD7B

P356

Q37126006-F1E9367C-3BA2-47AF-9EB3-C7F9F2C10807

P433

Q37126006-22DA45BA-A5BF-481A-A491-8246625E59CC

P478

Q37126006-3D3CAEA4-64E5-4A2C-8D27-D9858641B8E4

P50

Q37126006-40658626-76F2-42FC-B871-A815042F8983

Q37126006-C111131B-2F12-4B43-8470-285E9C894E83

Q37126006-FD9C7D77-5355-46E7-B45C-0888A02DCF0F

P577

Q37126006-91E34592-5825-43D6-B40D-924D81D36BB6

P5875

Q37126006-7B3B05E1-E1EF-45E7-B551-29C07114FF8A

P698

Q37126006-2D659A15-BC96-41C9-A6D1-6F19284AEFE1

P921

Q37126006-B97EAA81-2F81-4BAF-B7E1-7C85FFD73E09

P932

Q37126006-B5BBBBBE-4583-421C-ABD2-14F2EDD907D0

P356

P1433

Biomarkers in Medicine

P1476

Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

@en

P2093

Glen P Marszalowicz

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

VEGF inhibition and renal thrombotic microangiopathy

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Suicide gene therapy to increase the safety of chimeric antigen receptor-redirected T lymphocytes

P304

23-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/BMM.12.110

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Michael S Magee

Scott A. Waldman

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235414055

http://www.w3.org/2001/XMLSchema#string

P698

23387482

http://www.w3.org/2001/XMLSchema#string

P921

P932

3755011

http://www.w3.org/2001/XMLSchema#string